| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.82M | -10,000 | |
| VP | 83.7K | $16.31M | - | |
| VP | 38.3K | $7.48M | - | |
| VP | 34.5K | $6.72M | - | |
| CFO | 33.4K | $6.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 716 | $175.79 | $125,865.64 | -1.0% | -0.3% | +19.1% | |
| Feb 27, 2025 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 528 | $172.61 | $91,138.08 | -1.3% | -0.1% | +23.5% | |
| Feb 27, 2025 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 824 | $172.61 | $142,230.64 | -1.2% | -0.1% | +23.5% | |
| Feb 20, 2025 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 604 | $170.99 | $103,277.96 | -1.5% | -1.0% | +17.6% | |
| Feb 20, 2025 | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 1,434 | $170.51 | $244,514.86 | -1.0% | -1.0% | +17.6% | |
| Feb 19, 2025 | Plewman Patrick | SVP For Diagnostic Services | Sell | 320 | $169.71 | $54,307.20 | -1.7% | +3.8% | +17.9% | |
| Feb 5, 2025 | Delaney Mark E | SVP &Chief Commercial Officer | Sell | 403 | $164.30 | $66,214.15 | -8.0% | +6.8% | +16.6% | |
| Feb 5, 2025 | Gregg Vicky B | Director | Sell | 1,250 | $164.57 | $205,710.00 | -6.9% | +6.8% | +16.6% | |
| Nov 29, 2024 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 35,146 | $163.07 | $5,731,301.51 | -24.4% | +5.5% | +16.3% | |
| Nov 27, 2024 | Doherty Catherine T.55 | EVP, Regional Businesses | Sale+OE | 33,103 | $162.99 | $5,395,484.41 | -16.7% | +7.4% | +15.8% |